• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Advanced Pain Remedies

edit

Advanced Pain Remedies is a biotechnology company focused on treating intractable chronic pain. The company is led by an experienced management team.

Advanced Pain Remedies is a wholly owned subsidiary of Cato BioVentures. The company’s lead compound, APR 102, is a substance P-saporin (SP-SAP) conjugate that has shown efficacy in animal models of pain.

Recent Milestones

edit

• 
  Advanced Pain Remedies — Advanced Pain Remedies, a Subsidiary of Cato BioVentures, Announces a Three Million Dollar Award from the National Cancer Institute for SP-SAP (1/10/11)
  Posted 1/12/11 at 4:03am via earthtimes.org

Videos

Screenshots

edit

Above: Advanced Pain Remedies
Uploaded: 1/12/11

Sources

Advanced Pain Remedies, a Subsidiary of Cato BioVentures, Announces a Three Million Dollar Award from the National Cancer Institute for SP-SAP (earthtimes.org) [edit]